Data / Form D filings / Edge Therapeutics, Inc.
Edge Therapeutics, Inc.: Form D filings
Edge Therapeutics, Inc., a pharmaceuticals company in Berkeley Heights, NJ, filed 7 Form D notices with the SEC between 2009 and 2015. The latest, on April 9, 2015, reports $56 million sold of a $56 million offering to 19 investors.
Find out what Edge Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 200 CONNELL DRIVE, SUITE 1600, Berkeley Heights, NJ, 07922
- Phone
- (800) 208-3343
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1472091
The full lists. Form D filings in New Jersey: 714 rows, $35.70, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 9, 2015 | New notice | $56,000,000 | $55,999,978 | $22 | 19 | Apr 6, 2015 | sec.gov |
| Nov 13, 2014 | New notice | $25,000,000 | $7,937,236 | $17,062,764 | 104 | Nov 3, 2014 | sec.gov |
| Mar 25, 2013 | New notice | $20,000,000 | $6,673,405 | $13,326,595 | 52 | Mar 18, 2013 | sec.gov |
| Sep 17, 2012 | New notice | $3,000,000 | $118,500 | $2,881,500 | 2 | Aug 31, 2012 | sec.gov |
| Jun 24, 2011 | New notice | $2,750,000 | $219,500 | $2,530,500 | 5 | Apr 20, 2011 | sec.gov |
| Nov 8, 2010 | Amendment | $2,000,000 | $634,500 | $1,365,500 | 16 | Aug 18, 2009 | sec.gov |
| Sep 16, 2009 | New notice | $2,000,000 | $500,000 | $1,500,000 | 1 | Aug 18, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Andrew Loch Einhorn | Executive Officer | |
| James J. Loughlin | Director | |
| Isaac J. Blech | Director | |
| Albert N. Marchio II | Executive Officer | |
| Robert J. Spiegel | Director | |
| Kurt J. Conti | Director | |
| Robert Loch Macdonald | Executive Officer, Director | |
| Herbert J. Faleck | Executive Officer | |
| Sol J. Barer | Director | |
| Carl J. Soranno | Executive Officer | |
| Brian A. Leuthner | Executive Officer, Director |
Other pharmaceuticals companies in New Jersey that filed recently
- Grace Therapeutics, Inc. $10 million · Aug 11, 2026
Every Form D from the week of Apr 6, 2015 · All recent filings in New Jersey · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Edge Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.